| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2007;115:2814-2821.)
© 2007 American Heart Association, Inc.
Congenital Heart Disease |
From the University of North Carolina (M.P.K., M.W.L., P.L.M., B.V.R., S.L.M., H.N.M., P.G.N., M.A.Z., M.R.K.), Chapel Hill; University Hospital Freiburg (H. Omran, H. Olbrich, T.S.), Freiburg, Germany; The Toronto Hospital for Sick Children (S.D.), Toronto, Canada; Concord Hospital (L.M.), New South Wales, Australia; Darmstädter Kinderkliniken Prinzessin Margaret (P.A.), Darmstädt, Germany; and University Hospital Cologne (L.L.), Cologne, Germany.
Correspondence to Dr Michael R. Knowles, Cystic Fibrosis/Pulmonary Research and Treatment Center, 7019 Thurston Bowles Bldg, CB7248, Chapel Hill, NC 27599-7248. E-mail knowles{at}med.unc.edu
Received June 30, 2006; accepted February 22, 2007.
| Abstract |
|---|
|
|
|---|
50% of PCD patients (Kartageners syndrome in PCD), and there are a few reports of PCD with heterotaxy (situs ambiguus), such as cardiovascular anomalies. Advances in diagnosis of PCD, such as genetic testing, allow the systematic investigation of this association. Methods and Results The prevalence of heterotaxic defects was determined in 337 PCD patients by retrospective review of radiographic and ultrasound data. Situs solitus (normal situs) and situs inversus totalis were identified in 46.0% and 47.7% of patients, respectively, and 6.3% (21 patients) had heterotaxy. As compared with patients with situs solitus, those with situs abnormalities had more ciliary outer dynein arm defects, fewer inner dynein arm and central apparatus defects (P<0.001), and more mutations in ciliary outer dynein arm genes (DNAI1 and DNAH5; P=0.022). Seven of 12 patients with heterotaxy who were genotyped had mutations in DNAI1 or DNAH5. Twelve patients with heterotaxy had cardiac and/or vascular abnormalities, and most (8 of 12 patients) had complex congenital heart disease.
Conclusions At least 6.3% of patients with PCD have heterotaxy, and most of those have cardiovascular abnormalities. The prevalence of congenital heart disease with heterotaxy is 200-fold higher in PCD than in the general population (1:50 versus 1:10 000); thus, patients with PCD should have cardiac evaluation. Conversely, mutations in genes that adversely affect both respiratory and embryological nodal cilia are a significant cause of heterotaxy and congenital heart disease, and screening for PCD is indicated in those patients.
Key Words: defects heart defects, congenital lung pediatrics transposition of great vessels
| Introduction |
|---|
|
|
|---|
1 in 15 000.1,2 Clinical disease reflects defective ciliary structure and function, and includes respiratory distress in term neonates, recurrent sinopulmonary infection, chronic otitis media, subfertility, and bronchiectasis.2 Diagnosis is usually confirmed by studies of ciliary function and ultrastructure, but more recently diagnosis has been facilitated by immunohistochemistry of cilia and measurements of nasal nitric oxide.2,3 Mutations that cause disease have been identified in 2 genes (DNAI1 and DNAH5) that code for ciliary outer dynein arm (ODA) proteins.4,5 Mutations in these genes are found in
35% of all PCD patients, and in as many as 60% of PCD patients with defects in the ciliary ODA.4,5
Editorial p 2793
Clinical Perspective p 2821
Abnormalities of thoraco-abdominal asymmetry occur in
50% of PCD patients.1,2 The organs are usually a mirror image of normal, which is situs inversus totalis (SI; Kartageners syndrome in PCD). SI occurs as a random phenomenon in PCD and reflects a loss of nodal ciliary function during embryogenesis.69
The recognition of heterotaxy in several PCD patients provoked more careful consideration of situs abnormalities in PCD. There is no consensus on the definition and classification of heterotaxy. Some authors use "situs ambiguus" and "heterotaxy" interchangeably as any abnormality of thoraco-abdominal asymmetry other than SI, whereas other authors suggest that "heterotaxy" includes 2 groups, SI and situs ambiguus.10,11
There are a number of recognized subtypes of heterotaxy, which are determined on the basis of cardiac atrium anatomy; left (polysplenia syndrome) and right (asplenia syndrome) disorders of isomerism sequence. The anatomic abnormalities associated with left and right isomerism have been described,1215 but an unusual combination of anatomic abnormalities can make it difficult to classify as left or right isomerism.14
An important consequence associated with heterotaxy is complex cardiac defects. Heterotaxy, which includes L-transposition of the great arteries, is associated with at least 3% of congenital heart disease (CHD).11 Earlier reports, which include autopsy series, suggested that the majority of patients with isomerism died in childhood because of CHD; however, interpretation of these reports alone leads to selection bias.12,1618 In contrast, patients with left and right isomerism have been identified with no functional cardiac defect and a normal life span.1922 Currently,
50% of patients with left isomerism with CHD survive to age 15.13,23
Although a few case reports have noted that some PCD patients have heterotaxy, which includes CHD,21,2428 polysplenia,21,2931 and asplenia syndromes,19,24 the prevalence of these anatomic variations in PCD is not known. We reviewed a large cohort of PCD patients to determine the prevalence of heterotaxy and CHD and to define the types of ciliary defects and genetic mutations in DNAI1 and DNAH5 among these patients.
| Methods |
|---|
|
|
|---|
Methodology to Identify Heterotaxy
Patients were ultimately subdivided into 3 distinct groups: situs solitus (SS; normal thoraco-abdominal asymmetry), SI (complete mirror image reversal of SS with no other defect) and heterotaxy (situs ambiguus [SA]; any thoracoabdominal asymmetry that differs from SS or SI). Heterotaxy was subdivided into 3 groups: left isomerism, right isomerism, and other (including isolated dextrocardia and abdominal SI). To define situs status, we used the chest x-ray for preliminary assessment: SS (left-sided cardiac apex and stomach bubble), SI (right-sided cardiac apex and stomach bubble), isolated dextrocardia (right-sided cardiac apex and left-sided stomach bubble), and abdominal SI (left-sided cardiac apex and right sided stomach bubble). To further determine classification of heterotaxy, we reviewed available computed tomography, magnetic resonance imaging, and abdominal sonographic and echocardiographic studies. If available studies did not allow classification, patients were contacted again to obtain relevant radiographic studies and surgical reports. Polysplenia was identified when the splenic mass was divided into fairly equal-sized masses that varied in number from 2 to 6 and ranged from 1 to 6 cm in diameter, which together approximated the mass of a normal spleen.14,32
Statistical Analysis
For the primary analysis, Fisher exact test was used to test for differences in the prevalence of 3 different types of ciliary defects and prevalence of mutations in DNAI1 and DNAH5 across groups of patients with SS, SI, and heterotaxy. Secondary analyses used Fisher exact test to compare pairs of situs groups (SS, SI, SA) and to compare patients with situs abnormalities to those with SS. A probability value of <0.05 was considered significant for all analyses; no adjustment was made for multiple comparisons.
The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
| Results |
|---|
|
|
|---|
|
|
|
Ciliary Defects
There is a clear shift in the types of ciliary defects across the 3 groups classified by situs status (P<0.001) (Table 2). Specifically, there was a decreasing prevalence of inner dynein arm and central apparatus ciliary defects, as well as an increasing prevalence of ODA defects from SS to SI to heterotaxy. The higher prevalence of ODA defects in patients with situs abnormalities (SI plus heterotaxy) was strikingly different from SS (P<0.001). This indicates that ODA defects are more commonly involved (and inner dynein arm and/or central defects are less commonly involved) in PCD patients with abnormalities of organ development or location.
|
Genetic Mutations
Genetic testing of 161 PCD patients for mutations in 2 ciliary ODA genes (DNAI1 and DNAH5) paralleled the pattern of increasing prevalence of ciliary ODA defects across the 3 situs groups (P=0.037) (Table 2). Specifically, there was an increasing prevalence of mutations from SS to SI to heterotaxy. The higher prevalence of mutations in patients with situs abnormalities (SI plus heterotaxy) was different from SS (P=0.022). The distribution of DNAI1 versus DNAH5 mutations were similar across the 3 situs groups, as were the number of mutated alleles (patients with 2 mutations ranged from 71% to 84% in the 3 situs groups), and types of mutation (frameshift/STOP alleles ranged from 83% to 92%).45
Heterotaxy Patients
There was an equal distribution of gender (11 females/10 males), and the mean age was 17 (range 1 to 54) years (Table 3). The clinical phenotype was consistent with PCD in all heterotaxy patients; 76% had respiratory distress as term neonates, and all adults (age
18 years) and 50% of pediatric patients (age <18 years) had bronchiectasis. Sixteen of the heterotaxy patients had characterization of the ciliary defect, and 14 patients had an ODA defect. Nasal nitric oxide was low in the 11 patients tested, consistent with PCD. Seven of 12 patients tested had at least 1 mutation in DNAI1 or DNAH5, and 5 patients had 2 mutations.45 Three patients with heterotaxy had siblings with PCD (2 with Kartageners syndrome) (Table 3). Another patient (UNC927) had a brother born preterm (32 weeks) who died at 2 days of life with left isomerism (polysplenia) and CHD. Other clinical features included pectus excavatum (2 of 21 patients) as per the Haller Index (Table 4).33 Intestinal malrotation (left-sided appendectomy) was identified in only 1 patient (UNC875).
|
|
Laterality Defect Subtypes
The distribution of heterotaxic subtypes in 21 PCD patients is illustrated (Figure 1) and anatomic findings are summarized (Table 4). Eleven patients had left isomerism, which included 6 patients with polysplenia and cardiac and/or vascular anomalies (3 patients had CHD) (Figure 3, Table 4). One patient had right isomerism (Figure 4).19 Nine patients had other heterotaxic anomalies (3 patients with SI plus CHD; 3 patients with abdominal SI; 2 patients with isolated dextrocardia; and 1 patient with SS with CHD) (Figure 2). Five patients had polysplenia, but without cardiovascular anomalies (2 patients with abdominal SI, 1 patient with SI, and 2 patients with SS).
|
|
Cardiac and/or Vascular Malformations
Twelve of the 21 PCD patients with heterotaxy had cardiac and/or vascular malformations. Four of these 12 patients had vascular anomalies alone (Tables 4 and 5
), and 8 patients had complex cardiac anomalies that required surgery. In 3 patients with CHD and left isomerism, the cardiac defects included double outlet right ventricle and atrioventricular canal defects. In another 3 patients with CHD and SI, there were atrial and ventricular septal defects and L-transposition of the great arteries. Of the other 2 patients with CHD, one had abdominal situs inversus and atrial and ventricular septal defects, and 1 patient had SS and tetralogy of Fallot. There were 8 other patients with left isomerism who did not have complex cardiac malformations.
|
| Discussion |
|---|
|
|
|---|
The classification of heterotaxic syndromes remains controversial.10,11,14 We attempted to characterize all heterotaxy (situs ambiguus) patients as right or left isomerism. However, 9 patients could not be characterized, despite abdominal and echocardiogram imaging in most of these patients. We classified 3 patients with SI and congenital heart disease as heterotaxy, because these patients did not have mirror image reversal of situs solitus. One patient classified as having right isomerism (asplenia, midline liver) had inferior vena cava interruption, although inferior vena cava interruption is unusual in right isomerism.17,19,35
The respiratory phenotypes of the PCD patients with heterotaxy match those without heterotaxy.2 Specifically, the majority of patients had respiratory distress at birth, typical sinopulmonary disease, and chronic otitis media (Table 3). Bronchiectasis was present in all adults and
50% of children.2,36,37
Strikingly, there was a 200-fold higher prevalence of CHD related to heterotaxy in PCD (1 in 50 patients) versus the general population (CHD related to heterotaxy: 1 in 10 000 patients).38 PCD is not routinely cited as a cause of CHD.39,40 We speculate that the diagnosis of PCD is not made in many PCD patients who also have heterotaxy and CHD. For instance, the diagnosis of PCD was not made in 1 patient (UNC930) until age 10 years and after cardiac surgery. The diagnosis of PCD must be considered in patients with CHD and heterotaxy, particularly in patients with recurrent respiratory symptoms. Conversely, patients diagnosed with PCD should have formal cardiac assessment, especially patients with heterotaxic anatomic defects such as polysplenia.
More than half the PCD patients with heterotaxy had polysplenia (left isomerism; 11 of 21 patients), and 1 additional patient had asplenia. A spectrum of anatomic anomalies was seen in PCD patients with polysplenia or asplenia, which ranged from splenic anomaly alone to vascular anomalies to CHD and lung isomerism. The severity of polysplenia syndrome varied even within a single family, as 1 patient had vascular without cardiac anomalies, but a brother had complex CHD.
The establishment of left-right axis in the embryo is complex.11 Embryonic nodal dysfunction is 1 cause of randomization of left-right asymmetry and involves 2 distinct types of embryonic nodal cilia (motile and nonmotile sensory).7,8,41 In PCD, it is hypothesized that SI reflects defective nodal ciliary motile function,4,6,42 and our clinical data support that hypothesis; specifically, PCD patients can manifest heterotaxy, and siblings with PCD can have different situs anomalies. The spectrum of heterotaxic anomalies identified, such as CHD, is consistent with animal models of heterotaxy.9,4345 In fact, 40% of mice with mutations in an axonemal dynein heavy chain gene (lrd; iv/iv mice) show visceral, cardiac, and venous malformations of heterotaxy and small litter sizes because of intrauterine death.9,45
The distribution of different types of ciliary defects and genetic mutations in PCD patients classified by situs status strongly support the concept that specialized embryonic nodal cilia play a key role in organ development and location. These nodal cilia are motile, even though they do not have the central apparatus (central pair microtubules or radial spokes); thus, the increasing prevalence of ODA defects (and decreasing prevalence of inner dynein arm and central apparatus defects) from SS to SI to heterotaxy is consistent with this concept.
Likewise, the distribution of mutations in 2 genes (DNAI1 and DNAH5) that code for respiratory and nodal ciliary ODA proteins are consistent with this concept; ie, there is an increased prevalence of mutations from SS to SI to heterotaxy. Stated another way, genetic mutations that do not affect the outer ciliary microtubule doublets in the nodal cilia (such as central apparatus genes) are less likely to result in SI or heterotaxy. In support of this concept, mice deficient in Mdnah5 (murine homolog of DNAH5) also develop SI totalis and heterotaxy; these occur in association with ciliary immotility and recurrent respiratory infections.46,47 Thus, PCD phenotypes with heterotaxy, such as polysplenia and CHD, are frequently associated with mutations in DNAI1 and DNAH5, and genetic testing is indicated in these patients. These observations broaden both the phenotypic spectrum of DNAI1 and DNAH5 mutations and our understanding of the genetic causes of heterotaxy, and have important clinical implications.
It is unclear why the prevalence of heterotaxy in PCD is only one-tenth as common as SS or SI, and it does not seem likely that the prevalence of heterotaxy would change substantially, even if all PCD patients underwent full radiographic and ultrasound imaging. It is possible that humans (like mice) with heterotaxy and life-threatening anomalies (such as CHD) may be dying in utero or in early life.45 Mutations in other as yet unidentified ciliary genes likely cause PCD and may have consequences for embryonic node function and left-right asymmetry pathways at other steps. Maternal diabetes, paternal cocaine use, and retinoic acid deficiency have also been associated with heterotaxy; however, we have no data on these confounders in our PCD patients.48
A previously unrecognized anomaly was the high prevalence of pectus excavatum (
10%) in our PCD patients with heterotaxy compared with the general population (0.3%).49 Although 1 PCD patient with pectus had previous cardiac surgery, the pectus excavatum was documented prior to surgery. Interestingly, pectus excavatum and CHD are described in other congenital disorders, such as Marfan syndrome and Noonan syndrome, and an association between pectus excavatum and SI has previously been identified.50 At this point, it is uncertain if there is a genetic or pathophysiological link between pectus excavatum, heterotaxy, and PCD.
In conclusion, we demonstrate that PCD is associated with a marked increase in the prevalence of heterotaxy with and without CHD. The association of ciliary motility defects and heterotaxy links ciliary dysfunction and CHD. Thus, cilia-related genes are excellent candidate genes for heterotaxy and CHD. Patients with SI or heterotaxic anomalies, particularly those with concomitant neonatal respiratory distress or chronic respiratory infections, are at risk to have an underlying defect in ciliary structure, function, and genetics, and should be evaluated for PCD and tested for genetic mutations in DNAI1 and DNAH5.
| Acknowledgments |
|---|
Sources of Funding
This project was supported by grants from the National Institute of Health (NIH RR00046, RO1 HL071798, and 1U54 RR019480-01) to Dr Knowles and HL04225 to Dr Noone. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH. This project was also supported by grants from the Deutsche Forschungsgemeinschaft (SFB592, DFG Om 6/2, and DFG Om 6/4) to Dr Omran.
Disclosures
Dr Molina has received research support from the North Carolina Biotech Center. The other authors report no conflicts.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. Alharthi, F. Mookadam, J. Collins, K. Chandrasekaran, L. Scott, and A. J. Tajik Extracardiac Venous Heterotaxy Syndrome: Complete Noninvasive Diagnosis by Multimodality Imaging Circulation, June 24, 2008; 117(25): e498 - e503. [Full Text] [PDF] |
||||
![]() |
M. Brueckner Heterotaxia, Congenital Heart Disease, and Primary Ciliary Dyskinesia Circulation, June 5, 2007; 115(22): 2793 - 2795. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |